Advertisement

Cancer Immunology, Immunotherapy

, Volume 66, Issue 9, pp 1243–1247 | Cite as

Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2–4, 2016

  • Dolores Gallardo-Rincón
  • Juan Pablo Marquez
  • Esteban CelisEmail author
Meeting Report

Abstract

This meeting in immuno-oncology brought together clinicians and scientists from United States, Canada, and México with the goal of breaking down international walls and establishing new collaborations.

Keywords  Cancer immunotherapy  Cancer vaccines CAR T cells Adoptive T cell therapy Immunomodulatory repurposed drugs 

Abbreviations

ACT

Adoptive T-cell therapy

β-AR

β-Adrenergic receptor

BiTE

Bi-specific T-cell engager

CAR

Chimeric antigen receptor

CICS

Centro de Investigación de Cancer en Sonora

CT

Cancer testis

HCC

Hepatocellular carcinoma

HGSC

High-grade serous ovarian cancer

IBF

Inflammatory breast cancer

MDA5

Melanoma Differentiation-Associated protein 5

MDSC

Myeloid-derived suppressor cell

OS

Overall survival

PanIN

Pancreatic intraepithelial neoplasia

PDAC

Pancreatic ductal adenocarcinoma

Poly-IC

Polyinosinic polycytidylic acid

scFv

Single-chain variable fragment

TCGA

The cancer genome atlas

TIL

Tumor-infiltrating lymphocyte

TLR3

Toll-like receptor 3

Treg

T regulatory cell

Notes

Acknowledgements

This work was supported by grant from the National Cancer Institute of the National Institutes of Health, R01CA157303, and by start-up funds from Augusta University Cancer Center and the Georgia Research Alliance (GRA). Esteban Celis holds the Cecil F. Whitaker Jr. MD/GRA Eminent Scholar Chair in Tumor Immunology.

Compliance with ethical standards

Conflict of interest

Esteban Celis has filed patent applications based on the use of synthetic peptides and poly-IC combinatorial vaccines. The rights of the patent applications have been transferred to the Moffitt Cancer Center (Tampa, FL). All the other authors do not have any conflict of interest.

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Programa de Cáncer de OvarioInstituto Nacional de CancerologíaMexico CityMexico
  2. 2.Centro de Investigación en Cancer de SonoraSeattleUSA
  3. 3.Georgia Cancer CenterAugusta UniversityAugustaUSA

Personalised recommendations